ARVN
Arvinas Inc
NASDAQ: ARVN · HEALTHCARE · BIOTECHNOLOGY
$9.90
+0.81% today
Updated 2026-04-30
Market cap
$667.75M
P/E ratio
—
P/S ratio
2.54x
EPS (TTM)
$-1.14
Dividend yield
—
52W range
$6 – $15
Volume
0.9M
Arvinas Inc (ARVN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.67M | $7.58M | $14.32M | $42.98M | $21.80M | $46.70M | $131.40M | $78.50M | $263.40M | $262.60M |
| Revenue growth (YoY) | — | +13.6% | +89.0% | +200.0% | -49.3% | +114.2% | +181.4% | -40.3% | +235.5% | -0.3% |
| Cost of revenue | $22.88M | $31.99M | $0.00 | — | — | $6.00M | $8.20M | $6.70M | $6.60M | $5.20M |
| Gross profit | $6.67M | $7.58M | $14.32M | $42.98M | $21.80M | $46.70M | $131.40M | $78.50M | $263.40M | $257.40M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 98.0% |
| R&D | $19.94M | $28.79M | $45.19M | $67.19M | $108.36M | $180.40M | $315.00M | $379.70M | $348.20M | $282.90M |
| SG&A | $3.20M | $3.55M | $12.93M | $27.31M | $38.30M | $61.60M | $79.60M | $100.30M | $165.40M | $89.40M |
| Operating income | $-16.47M | $-24.76M | $-43.80M | $-51.52M | $-124.86M | $-195.30M | $-263.20M | $-401.50M | $-250.20M | $-114.90M |
| Operating margin | -247.0% | -326.7% | -305.8% | -119.9% | -572.7% | -418.2% | -200.3% | -511.5% | -95.0% | -43.8% |
| EBITDA | $-13.93M | $-23.65M | $-43.10M | $-49.27M | $-120.83M | $-189.30M | $-255.00M | $-394.80M | $-243.60M | $-75.30M |
| EBITDA margin | -208.9% | -312.1% | -300.9% | -114.6% | -554.2% | -405.4% | -194.1% | -502.9% | -92.5% | -28.7% |
| EBIT | $-14.37M | $-24.00M | $-43.80M | $-51.52M | $-124.86M | $-195.30M | $-263.20M | $-401.50M | $-250.20M | $-80.50M |
| Interest expense | $67404.00 | $50357.00 | $57440.00 | $85569.00 | $65000.00 | $100000.00 | $12.00M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-14.35M | $-24.05M | $-41.48M | $-62.13M | $-111.79M | $-183.20M | $-271.90M | $-367.30M | $-198.90M | $-80.80M |
| Net income growth (YoY) | — | -67.6% | -72.5% | -49.8% | -79.9% | -63.9% | -48.4% | -35.1% | +45.8% | +59.4% |
| Profit margin | -215.2% | -317.3% | -289.6% | -144.6% | -512.7% | -392.3% | -206.9% | -467.9% | -75.5% | -30.8% |